文献速递重症综合管理与镇静镇痛儿科与产科急症

儿科体外膜氧合支持中的红细胞输注实践

RBC Transfusion Practice in Pediatric Extracorporeal Membrane Oxygenation Support.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论多中心前瞻性观察研究显示,儿科体外膜氧合患者每日红细胞输注量每增加10 mL/kg/d,住院死亡 odds 独立增加9%(aOR 1.09,95%CI 1.02–1.16)。

该研究为多中心前瞻性观察研究的二次分析,纳入8家儿科机构中年龄小于19岁、接受体外膜氧合治疗的患者。每日记录目标血红蛋白或血细胞比容值(如有设定)、接近上午8点所测血红蛋白与血细胞比容,以及每日红细胞输注总量(mL/kg)。队列平均目标血细胞比容范围为27.5%–41.3%,实际平均每日血细胞比容为36.8%,体外膜氧合期间平均红细胞输注量为29.4 mL/kg/d(17.4–49.7 mL/kg/d)。多因素分析校正潜在混杂因素后,红细胞输注量每增加10 mL/kg/d与住院死亡 odds 增加9%独立相关(aOR 1.09,95%CI 1.02–1.16,P=0.009)。作者认为亟需未来临床研究确定儿科体外膜氧合的最佳红细胞输注阈值。

要点

  • 多中心前瞻性观察研究二次分析,8家儿科机构,纳入年龄小于19岁、接受体外膜氧合治疗的患者。
  • 队列平均目标血细胞比容范围为27.5%–41.3%,实际平均每日血细胞比容为36.8%。
  • 体外膜氧合期间平均红细胞输注量为29.4 mL/kg/d(17.4–49.7 mL/kg/d)。
  • 校正混杂因素后,红细胞输注量每增加10 mL/kg/d与住院死亡 odds 增加9%独立相关(aOR 1.09,95%CI 1.02–1.16,P=0.009)。
  • 作者认为亟需未来临床研究确定儿科体外膜氧合的最佳红细胞输注阈值。

适用人群与场景

  • 年龄小于19岁、在参与中心接受体外膜氧合治疗的儿科患者。
  • 来自8家儿科机构,均属美国国立儿童健康与人类发育研究所协作儿科重症监护研究网络。

研究设计与关键结果

  • 研究类型:多中心前瞻性观察研究的二次分析,8家儿科机构,年龄小于19岁接受体外膜氧合治疗的患者。
  • 干预与对照:无干预;记录每日目标血红蛋白或血细胞比容值(如有设定)、接近上午8点所测血红蛋白与血细胞比容,以及每日红细胞输注总量(mL/kg)。
  • 主要终点结果:多因素 logistic 回归校正潜在混杂因素后,红细胞输注量每增加10 mL/kg/d与住院死亡 odds 增加9%独立相关(aOR 1.09,95%CI 1.02–1.16,P=0.009)。
  • 其他结果:队列平均目标血细胞比容范围为27.5%–41.3%,实际平均每日血细胞比容为36.8%,体外膜氧合期间平均红细胞输注量为29.4 mL/kg/d(17.4–49.7 mL/kg/d)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为亟需未来临床研究确定儿科体外膜氧合的最佳红细胞输注阈值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine RBC transfusion practice and relationships between RBC transfusion volume and mortality in infants and children treated with extracorporeal membrane oxygenation.

DESIGN: Secondary analysis of a multicenter prospective observational study.

SETTING: Eight pediatric institutions within the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Collaborative Pediatric Critical Care Research Network.

PATIENTS: Patients age less than 19 years old treated with extracorporeal membrane oxygenation at a participating center.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Clinical data and target hemoglobin or hematocrit values (if set) were recorded daily by trained bedside extracorporeal membrane oxygenation specialists and research coordinators. Laboratory values, including hemoglobin and hematocrit, were recorded daily using the value obtained closest to 8:00 AM. RBC transfusion was recorded as total daily volume in mL/kg. Multivariable logistic regression was used to determine the relationship between RBC transfusion volume and hospital mortality, accounting for potential confounders. Average goal hematocrits varied across the cohort with a range of 27.5-41.3%. Overall, actual average daily hematocrit was 36.8%, and average RBC transfusion volume was 29.4 mL/kg/d (17.4-49.7 mL/kg/d) on extracorporeal membrane oxygenation. On multivariable analysis, each additional 10 mL/kg/d of RBC transfusion volume was independently associated with a 9% increase in odds of hospital mortality (adjusted odds ratio, 1.09 [1.02-1.16]; p = 0.009).

CONCLUSIONS: In this multicenter cohort of pediatric extracorporeal membrane oxygenation patients, daily hematocrit levels were maintained at normal or near-normal values and RBC transfusion burden was high. RBC transfusion volume was independently associated with odds of mortality. Future clinical studies to identify optimum RBC transfusion thresholds for pediatric extracorporeal membrane oxygenation are urgently needed.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Muszynski JA, Reeder RW, Hall MW, et al. RBC Transfusion Practice in Pediatric Extracorporeal Membrane Oxygenation Support. Crit Care Med. 2018. PMID: 29517551. doi:10.1097/CCM.0000000000003086

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。